» 公司新聞 » Zhong Nanshan: COVID-19 的可追溯性尚未完成

Zhong Nanshan: COVID-19 的可追溯性尚未完成

2020-11-17

11月16日, 2020 廣州國際生物論壇在廣州國際生物島舉行, 主題為 “科技創新引領健康未來”. Zhong Nanshan, 共和國勳章得主、中國工程院院士, 鐘南山出席論壇並致辭: COVID-19 的可追溯性尚未完成.

Zhong Nanshan said that it is unimaginable for so many people to meet together today in foreign countries. 現在, there are still many major problems unsolved in COVID-19, the law of COVID-19 outbreak has not been understood, the traceability has not been completed, and there are no highly targeted and effective drugs. Pfizer vaccine abroad can prevent 90% of infections, and vaccine research and development in China is at a similar level.

Zhong Nanshan said that at present, there is a great contrast between China and foreign countries in the prevention and control of the epidemic situation, which is because China took the idea oflife firstas a guide and timely controlled the domestic epidemic situation at the early stage of the outbreak.

This is very different from my experience in fighting SARS in 2003. At that time, scientific research was not done enough, but when the COVID-19 outbreak broke out, we had the support of science and technology. We could prevent and study while developing kits earlier and promote them quickly. ” Zhong Nanshan said that due to the combination of medical treatment and scientific research, the COVID-19 epidemic in China was quickly controlled.

Zhong Nanshan said that until today, many major problems of the epidemic have not been solved, such as the source of COVID-19 is still unclear, and targeted drugs have not yet appeared. Zhong Nanshan said that it depends on the combination of basic and clinical, clinical and enterprise. “Shorten this road a little, this is the direction of our efforts.

According to Zhong Nanshan, Pfizer vaccine abroad can prevent 90% of infections. 實際上, the level of vaccine research and development in Guangdong and even China is similar, but the results of the first phase of the trial can only be announced.

On September 24th, at the 13th China Bio-industry Conference, Academician Zhong Nanshan said that the pneumonia epidemic in COVID-19 may continue to exist or develop this winter and next spring. He introduced that it takes 1 至 2 years to complete mass vaccination.

新冠疫苗 新冠疫苗

也許你也喜歡

  • 關於我們


    醫療技術公司, 有限公司. 是中國醫療用品的專業製造商, 我們生產和銷售尼龍植絨棉籤, VTM套件, 唾液收集套件和 CHG 拭子 & 塗抹器.

  • 聯繫我們

    地址: 房間 201, 301 和 401 A座10號, 寶龍五路, 同樂社區, 寶龍街, 龍崗區,深圳, 粵, 中國.

    網絡: www.medicoswab.com

    電話號碼: +86 0755-28997664

    電子郵件: info@medicoswab.com